arrow
F

Frank A. Post

King's College Hospital NHS Foundation Trust
H指数:62
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Antiviral Effect, Safety, and Tolerability of Oral VH4011499, a New Human Immunodeficiency Virus Capsid Inhibitor: Proof-of-Concept Trial

口服VH4011499的抗病毒效果、安全性与耐受性:一项概念验证试验

2026-07-290
OAAI
Safety and biologic activity of a bispecific T cell receptor targeting HIV Gag in males living with HIV: a first-in-human trial

靶向HIV Gag的双特异性T细胞受体在男性HIV感染者中的安全性和生物活性: 首次人体试验

2026-01-310
OA
Effectiveness and safety of two-drug regimens containing an integrase inhibitor and reverse transcriptase inhibitor in a cohort of virologically suppressed people with HIV: Data from the COMBINE-2 study
2026-01-010
OAAI
Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trial

整合酶抑制剂与蛋白酶抑制剂疗法在晚期HIV疾病中的比较(LAPTOP):一项多国家、随机、开放标签、非劣效性试验

2025-12-010
OAAI
Outcomes of switching from protease inhibitor-based antiretroviral therapy to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in virologically suppressed adults with nucleos(t)ide analogue resistance- a phase IV randomised, open-label study (PIBIK study)
2025-02-100
OAAI
Genetic Variants of APOL1 Are Major Determinants of Kidney Failure in People of African Ancestry With HIV (vol 7, pg 786, 2022)
2024-12-010
OAAI
MAVMET trial: maraviroc and/or metformin for metabolic dysfunction associated fatty liver disease in adults with suppressed HIV
AIDS
IF3.1
2024-06-251
OAAI